A three-dose inactivated SARS-CoV-2 vaccine is sufficient to elicit humoral immune responses in people living with HIV-1
Main Authors: | Haisheng Yu, Pengle Guo, Yingyin Yang, Jun Dai, Xiaoping Tang, Linghua Li, Yanjie Yin |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2023-09-01
|
Series: | Chinese Medical Journal |
Online Access: | http://journals.lww.com/10.1097/CM9.0000000000002810 |
Similar Items
-
Humoral Responses Elicited by SARS-CoV-2 mRNA Vaccine in People Living with HIV
by: Lorie Marchitto, et al.
Published: (2023-09-01) -
A third (booster) dose of the inactivated SARS-CoV-2 vaccine elicits immunogenicity and T follicular helper cell responses in people living with HIV
by: Zhengchao Lv, et al.
Published: (2023-11-01) -
Six-month humoral immune response to inactivated COVID-19 vaccine among people living with HIV
by: Shi Zou, et al.
Published: (2022-10-01) -
Humoral immune response to inactivated COVID-19 vaccination at the 3rd month among people living with HIV
by: Songjie Wu, et al.
Published: (2023-01-01) -
Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV
by: Alrubayyi, A, et al.
Published: (2021)